Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Scandinavian Cardiovascular Journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/14017439709069548PMID 9498931
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.

  1996cited by this paper
• Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study.

  1996cited by this paper
• Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.

  1996cited by this paper
• Heparin-coated circuit in coronary surgery. A clinical study.

  1996cited by this paper
• The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function.

  1995cited by this paper
• Circulating cytokines and granulocyte-derived enzymes during complex heart surgery. A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits.

  1995cited by this paper
• Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass.

  1995cited by this paper
• Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

  1995cited by this paper
• Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss.

  1994cited by this paper
• Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood.

  1994cited by this paper
• Mechanisms of thrombin generation during surgery and cardiopulmonary bypass [see comments]

  1993cited by this paper
• Mechanisms of thrombin generation during surgery and cardiopulmonary bypass.

  1993cited by this paper
• Inhibition of platelet function by heparin. An etiologic factor in postbypass hemorrhage.

  1993cited by this paper
• Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations.

  1992cited by this paper
• Decreased blood loss after cardiopulmonary bypass using heparin-coated circuit and 50% reduction of heparin dose.

  1992cited by this paper
• Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

  1992cited by this paper
• Heparin-coating of extracorporea circuits reduces thrombin formation in patients undergoing cardiopulmonary bypass

  1991cited by this paper
• Platelet and neutrophil activation in cardiopulmonary bypass.

  1990cited by this paper
• Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization.

  1990cited by this paper
• Antithrombin III Binding to Surface Immobilized Heparin and Its Relation to F Xa Inhibition

  1987cited by this paper
• Studies on components of the plasma kallikrein-kinin system in patients undergoing cardiopulmonary bypass.

  1986cited by this paper
• Coagulation, fibrinolysis and bleeding after open-heart surgery.

  1986cited by this paper
• Thrombin inactivation on surfaces with covalently bonded heparin.

  1986cited by this paper
• Hemostasis Changes During Cardiopulmonary Bypass Surgery

  1985cited by this paper
• A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue.

  1983cited by this paper
• Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture.

  1982cited by this paper
• Factor VIII-related antigen in human blood platelets: localization and release by thrombin and collagen.

  1979cited by this paper
• Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

  1966cited by this paper
• Immunochemical quantitation of antigens by single radial immunodiffusion.

  1965cited by this paper
• Determination of Fibrinogen and Fibrinogenolytic Activity

  1962cited by this paper

• The In vitro Effects on Platelet Functions and Coagulation of Different Prime Solutions Used in Cardiopulmonary by Pass

  2016cites this paper
• Comparison of Sarns 3M heparin bonded to Duraflo II and control circuits in a porcine model: macro- and microanalysis of thrombi accumulation in circuit arterial filters

  2000cites this paper
• Pro and con of heparin-bonded circuits for cardiopulmonary bypass.

  1999cites this paper